← Back to Search

30-day ambulatory cardiac event monitor for Heart Failure (SIMPL-AF Trial)

N/A
Waitlist Available
Led By Jason G Andrade, MD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days and 1-year
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the rates of new-onset AF in patients who are discharged home in sinus rhythm after a myocardial infarction (MI), with and without an external loop recorder.

Eligible Conditions
  • Heart Failure
  • Heart Attack
  • Atrial Fibrillation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days and 1-year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days and 1-year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of new-onset AF at 30-days post-MI
Secondary study objectives
AF-related hospitalization
Composite cardiovascular and hospitalization events
Rate of oral anticoagulation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intensive MonitoringExperimental Treatment1 Intervention
30-day ambulatory cardiac event monitoir
Group II: Standard CareActive Control1 Intervention
Standard Care (no supplemental monitoring)

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,465 Previous Clinical Trials
2,485,257 Total Patients Enrolled
10 Trials studying Heart Failure
5,848 Patients Enrolled for Heart Failure
Jason G Andrade, MDPrincipal InvestigatorUniversity of British Columbia
~30 spots leftby Nov 2025